Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

Cancel

BSE Code : 539524 | NSE Symbol : LALPATHLAB | ISIN : INE600L01024 | Industry : Healthcare |

(25-Apr-25 15:23) Board of Dr. Lal PathLabs recommends final dividend
(25-Apr-25 15:23) Dr. Lal PathLabs to convene AGM
(25-Apr-25 14:47) Dr Lal Pathlabs consolidated net profit rises 83.20% in the March 2025 quarter
(19-Apr-25 10:39) Dr. Lal PathLabs schedules board meeting
(15-Apr-25 14:09) Dr Lal Pathlabs introduces highly specialized Amyloidosis test
(25-Feb-25 15:00) Dr Lal Pathlabs Ltd leads losers in 'A' group
(18-Feb-25 18:20) Dr Lal Pathlabs allots 4,000 equity shares under ESOP
(30-Jan-25 14:39) Dr Lal Pathlabs consolidated net profit rises 18.94% in the December 2024 quarter
(30-Jan-25 14:09) Board of Dr. Lal PathLabs recommends Third Interim dividend
(23-Jan-25 17:28) Dr. Lal PathLabs to conduct board meeting

1 2 3 4 5 6 7 8 9 10

Dr Lal Pathlabs Ltd